Botanical species · safety record

Picramnia antidesma

The EFSA Compendium of Botanicals holds 8 constituent measurements for Picramnia antidesma. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Picramnia antidesma Sw.

8Constituent measurements

0Safety records

5Cited sources

0Licensed products (Canada)

Regulatory presence

No Health Canada licensed natural health product in the snapshot names this species as a medicinal ingredient under this exact binomial. Absence here means absence from this one register under this one name, not absence from trade, and not a safety verdict.

What the records describe

Constituents measured

Plant parts

Preparations

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
Aloe-emodin	Leaves	Solvent extraction	—	Nuclear Magnetic Resonance (NMR)	Resolve DOI
Anthraquinones	Roots and other underground parts	Solvent extraction	—	Nuclear Magnetic Resonance (NMR)	Resolve DOI
Anthraquinones	Unspecified	Solvent extraction	—	Unspecified	Resolve DOI
Anthrones	Stem / stalk	Solvent extraction	—	Colorimetry, Spectroscopy (Spectrometry) and Photometry	Resolve DOI
Chrysophanol	Roots and other underground parts	Solvent extraction	—	Standard Chromatographic tests (paper- thin layer- and column chromatography)	Resolve DOI
Coumarin	Roots and other underground parts	Solvent extraction	—	Standard Chromatographic tests (paper- thin layer- and column chromatography)	Resolve DOI
Emodin	Roots and other underground parts	Solvent extraction	—	Standard Chromatographic tests (paper- thin layer- and column chromatography)	Resolve DOI
Picramnioside a	Leaves	Solvent extraction	—	Nuclear Magnetic Resonance (NMR)	Resolve DOI

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

Hernandez-Medel, MD., Ramirez-Corzas, CO., Rivera-Dominguez, MN., Ramirez-Mendez, J., Santillan, R., Rojas-Lima, S. Diastereomeric C-glycosyloxanthrones from picramnia antidesma. Phytochemistry, 1999, vol. 50, no. 8, p. 1379-1383. DOI
SOLIS, PN., RAVELO, AG., GONZALEZ, AG., GUPTA, MP., PHILLIPSON, JD. BIOACTIVE ANTHRAQUINONE GLYCOSIDES FROM PICRAMNIA-ANTIDESMA SSP FESSONIA. Phytochemistry, 1995, vol. 38, no. 2, p. 477-480. DOI
Hernandez-Medel, MD., Pereda-Miranda, R. Cytotoxic anthraquinone derivatives from Picramnia antidesma. Planta medica, 2002, vol. 68, no. 6, p. 556-558. DOI
Hernandez-Medel, MD., Garcia-Salmones, I., Santillan, R., Trigos, A. An anthrone from Picramnia antidesma. Phytochemistry, 1998, vol. 49, no. 8, p. 2599-2601. DOI
Jacobo-Herrera, N.J., Jacobo-Herrera, F.E., Zentella-Dehesa, A., Andrade-Cetto, A., Heinrich, M., P�rez-Plasencia, C. Medicinal plants used in Mexican traditional medicine for the treatment of colorectal cancer. Journal of ethnopharmacology, 2016, vol. 179, p. 391-402. DOI

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature